Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
05 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/04/3093434/0/en/Vigil-Neuroscience-Provides-Update-on-Iluzanebart-Phase-2-IGNITE-Trial-in-ALSP.html
22 May 2025
// PRESS RELEASE
https://www.sanofi.com/en/media-room/press-releases/2025/2025-05-21-23-15-31-3086232
24 Jan 2025
// BIOSPACE
https://www.biospace.com/business/biogen-trims-research-workforce-higher-dose-sma-drug-accepted-for-regulatory-review
17 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/09/17/2947269/0/en/Vigil-Neuroscience-Announces-FDA-Has-Removed-Partial-Clinical-Hold-on-VG-3927.html
16 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/en/news-release/2024/09/16/2947018/0/en/Vigil-Neuroscience-to-Present-at-Cantor-Global-Healthcare-Conference.html
26 Sep 2023
// PRESS RELEASE
https://investors.vigilneuro.com/news-releases/news-release-details/vigil-neuroscience-receives-positive-opinion-european-medicines
ABOUT THIS PAGE